✦ LIBER ✦

Clinical genotyping and efficacy outcomes: Exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer

✍ Scribed by Pallaud, Celine; Reck, Martin; Juhasz, Erzsebet; Szima, Barna; Yu, Chung-Jen; Burdaeva, Olga; Orlov, Sergey; Hilton, Magalie; Archer, Venice; Mok, Tony

Book ID: 127364342
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 405 KB
Volume: 86
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2014.07.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of erlotinib in combina

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

✍ Ciuleanu, T.; Tsai, C.-M.; Tsao, C.-J.; Milanowski, J.; Amoroso, D.; Heo, D.S.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 718 KB

Safety and efficacy of first-line bevaci

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study

✍ Lucio Crinò; Eric Dansin; Pilar Garrido; Frank Griesinger; Janessa Laskin; Nick 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 204 KB

9170 Safety and efficacy of first-line b

9170 Safety and efficacy of first-line bevacizumab (Bv) plus chemotherapy in elderly patients (pts) with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): SAiL (MO19390)

✍ Garrido, P.; Thatcher, N.; Crino, L.; Dansin, E.; Laskin, J.; Pavlakis, N.; Tsai 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A multicenter phase II study of docetaxe

A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)

✍ Raez, Luis E.; Santos, Edgardo S.; Webb, R. Timothy; Wade, James; Brito, Roger A 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 324 KB

9149 Phase II study of bevacizumab in co

9149 Phase II study of bevacizumab in combination with cisplatin and docetaxel as first line treatment of patients (p) with metastatic non squamous non-small-cell lung cancer (NSCLC)

✍ Ferrer, N.; Cobo, M.; Paredes, A.; Méndez, M.; Muñoz-Langa, J.; Rueda, A.; de Mo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

9160 Molecular and clinical biomarkers o

9160 Molecular and clinical biomarkers of outcome with cetuximab: Data from the phase III FLEX study in non-small cell lung cancer (NSCLC)

✍ O'Byrne, K.; Pereira, J. Rodrigues; vonPawel, J.; Szczesna, A.; Waller, C.; Barr 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB